ClinicalTrials.gg
Active, not recruitingNCT07539480CP syndromeUpdated Apr 20, 2026

Pain Neuroscience Education Versus Kinesio Tape on Functional Outcomes in Patients With Carpal Tunnel Syndrome

An interventional study of group A: pain neuroscience education (PNE) and group B: Patients receive Kinesio Taping in Carpal Tunnel Syndrome (CTS), sponsored by Middle East University. Active, not recruiting at 1 site in Egypt. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Middle East University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jun 2025, registered Apr 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Carpal Tunnel Syndrome with a site in Egypt — 20 open to participants now, 22 under way, 1 of them phase 3. Carpal Tunnel Syndrome · Egypt.

Enrollment
21st of 53
60 · median 60
Started
2025
with 5 others
No phase
44 of 64
12 open now
Primary completion
2027-09
later than 21 of 21 live
Registered
60th of 64
by date

Among the 64 studies in Carpal Tunnel Syndrome with a site in Egypt, this one is the 21st largest by enrollment of the 53 interventional ones that give a count, is one of 6 that started in 2025, is one of 44 with no phase, reaches primary completion later than 21 of the 21 other live ones, and was the 60th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

20 of the 64 studies in Carpal Tunnel Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 20 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Carpal Tunnel Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

Carpal Tunnel Syndrome (CTS) is one of the most common compressive neuropathies of the upper limb, characterized by pain, numbness, and functional impairment due to median nerve compression at the wrist. Its prevalence is estimated at approximately 4.9%, with higher incidence in populations exposed to repetitive hand movements. The resulting sensory disturbances, grip weakness, and functional limitations significantly affect daily activities and quality of life.

Conservative management remains the first line of treatment for mild to moderate CTS, with therapeutic approaches traditionally including splinting, exercise therapy, nerve mobilization, and patient education. Recent interest has grown around Pain Neuroscience Education (PNE)-an educational strategy that reframes patients' understanding of pain by emphasizing the role of the central nervous system, cognitive factors, and neurophysiological processes. Studies have shown that PNE, particularly when combined with exercise or standard rehabilitation, can reduce symptom severity, improve functional outcomes, and help patients better manage chronic pain by reducing fear and catastrophizing. However, the existing literature notes that research on PNE for CTS is still limited, with some trials suggesting positive outcomes but calling for more high-quality evidence.

In parallel, Kinesio Taping (KT) has gained popularity as a noninvasive intervention believed to enhance circulation, provide proprioceptive input, and support soft tissue mobility. Evidence from randomized controlled trials shows that KT can improve grip strength, reduce pain intensity, enhance sensory conduction velocity, and improve functional status as measured by validated clinical tools such as the Boston Carpal Tunnel Questionnaire. These findings suggest that KT may serve as an effective supplementary therapy in the conservative management of CTS

Read the detailed description

Objective: The purpose of this study was to compare between pain neuroscience education and Kinesio tape on functional outcomes in patients with carpal tunnel syndrome Methods: This study involved 60 patients with carpal tunnel syndrome, consisting of 30 females and 20 males, ranging in age from 20 to 50 years. All participants were allocated into two groups: Group (A) patients with pain neuroscience education, Group (B) patients Kinesio tape

03

Conditions studied

  • Carpal Tunnel Syndrome (CTS)

Keywords

  • Kinesio tape
  • carpal tunnel syndrome
04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18 to 60 years.
  • Clinically diagnosed unilateral or bilateral carpal tunnel syndrome based on standard diagnostic criteria (e.g., pain, numbness, or tingling in the median nerve distribution), with or without confirmation by nerve conduction studies.
  • Patients with mild to moderate carpal tunnel syndrome, defined by clinical assessment and electrodiagnostic findings.
  • Symptoms present for at least 3 months.
  • Reported wrist or hand pain with functional limitations affecting daily activities.

Exclusion criteria

Exclusion Criteria:

  • Severe CTS characterised by significant thenar muscle atrophy or severe nerve conduction impairment.
  • Previous Surgery or Injection:
  • History of carpal tunnel release surgery or injection to the wrist within the past 6 months.
  • Presence of other conditions affecting the upper limb, such as cervical radiculopathy, peripheral neuropathy, rheumatoid arthritis, tendon rupture, or fractures.
  • Known neurological disorders (e.g., stroke, multiple sclerosis) or systemic diseases affecting nerve function (e.g., uncontrolled diabetes mellitus).
  • Skin disease, open wounds, or known allergy to adhesive materials that contraindicate kinesio taping.
  • Pregnant women, due to possible changes in fluid retention and nerve compression.
  • Participation in other physical therapy or pain education programmes targeting the upper limbs during the study period.
  • Conditions that limit comprehension of pain neuroscience education material or ability to provide reliable responses to questionnaires.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    group A: pain neuroscience education (PNE)

    PNE Components

    Other: group A: pain neuroscience education (PNE)

  • Experimental
    group B: Patients receive Kinesio Taping

    KT Application Technique

    Other: group B: Patients receive Kinesio Taping

Interventions

  • Othergroup A: pain neuroscience education (PNE)

    1- Education on neurobiology and neurophysiology of pain 2- How beliefs and behaviours influence pain 3- Central sensitization and pain amplification 4- Use of metaphors, visuals, and interactive discussion the frequency of the session 1- 1 session/week, 30-40 minutes 2- Duration: 6 weeks 3- Delivered by a trained physiotherapist

  • Othergroup B: Patients receive Kinesio Taping

    KT Application Technique 1- Elastic tape placed along flexor retinaculum and median nerve pathway 2- Tension: 10-15% 3- Reapplied twice weekly 4- Duration: 6 weeks

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    self-reported pain intensity scale ranging from 0 (no pain) to 10 (worst imaginable pain), assessing average hand pain over the past week.

    Time frame: 8 weeks

  2. Boston Carpal Tunnel Questionnaire

    The BCTQ is a tool that assesses difficulty in performing daily activities of the hand such as writing, gripping and lifting objects It consists of eight items, each scored from 1 (no difficulty) to 5 (unable to perform activity). Higher scores indicate greater functional disability.

    Time frame: 8 months

  3. Jamar Hand-Held Dynamometer (kg)

    Assess the maximum voluntary grip strength of the affected hand. Three trials are recorded, and the mean value is used for analysis.

    Time frame: 8 months

07

Study locations

1 site
  • Bassam Ahmed Nabil
    October City, Giza Governorate 6892, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Sep 2027, 27 months after the start.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 27 months is above that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2026
First posted
Apr 20, 2026
StartActual
Jun 15, 2025
Primary completionEst.
Sep 20, 2027
CompletionEst.
Sep 20, 2027
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07539480
Lead sponsor
Middle East University
Responsible party
Emad Eldin Mohamed (associate professor, Middle East University) — Principal investigator
First posted
Apr 20, 2026
Start date
Jun 15, 2025
Primary completion
Sep 20, 2027 (estimated)
Completion
Sep 20, 2027 (estimated)
Last update
Apr 20, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion